Cullinan Therapeutics outlines Q4 2026 data milestones for CLN-978, velinotamig and CLN-049

Cullinan Therapeutics announced planned Q4 2026 data readouts for CLN-978, velinotamig and CLN-049.Key Highlights:Original SEC Filing: Cullinan Therapeutics, Inc. [ CGEM ] - 8-K - Sep. 24, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with…